Xifaxan News

THURSDAY, March 24, 2016 – Two decades of progress toward eliminating tuberculosis in the United States has stalled, with incidence of the lung disease holding steady from 2013 to 2015, a federal government report shows. "Resuming progress toward TB elimination in the United States will require intensification of efforts both in the U.S. and globally," said researchers from the U.S. Centers for ...

-- By taking an antibiotic as prescribed, you can get well faster and help prevent germs from becoming resistant to your medication. The U.S. Centers for Disease Control and Prevention offers these antibiotic guidelines: Never skip a dose of antibiotic. Always take it on schedule, as directed. Never stop taking an antibiotic early. Always take the entire prescription, unless your doctor tells ...

MONDAY, Nov. 16, 2015 – Overuse of antibiotics in farm animals poses a real health risk to children, the American Academy of Pediatrics warns in a new report. This common practice is already contributing to bacterial resistance to medicines and affecting doctors' ability to treat life-threatening infections in kids, according to the paper published online Nov. 16 in the journal Pediatrics. One ...

MONDAY, Oct. 5, 2015 – A relatively new antibiotic-resistant bacteria called CRE is making inroads in some major American cities, U.S. health officials report. Surveillance of seven U.S. metropolitan areas found higher-than-expected levels of CRE in Atlanta, Baltimore and New York City, according to the U.S. Centers for Disease Control and Prevention. Lower-than-expected levels were found in ...

FRIDAY, Sept. 18, 2015 – As concerns over antibiotic resistance grow around the world, researchers report they've discovered a promising new group of antibiotics. These new drugs contain iridium, a transition metal that doesn't break down easily. This may help the antibiotics treat superbugs, such as MRSA (methicillin-resistant Staphylococcus aureus), the researchers said. "We are still at the ...

TUESDAY, Aug. 4, 2015 – An immediate, focused effort to halt the spread of antibiotic-resistant germs could save tens of thousands of lives and prevent hundreds of thousands of new infections over the next five years, a new government report suggests. As many as 37,000 lives could be saved, and 619,000 new infections prevented, if community health departments and health care facilities form ...

TUESDAY, July 21, 2015 – The antibiotic dicloxacillin may lessen the effects of some blood-thinning medications, new research shows. "The surprise in the study was just how much of an impact dicloxacillin had," said study author Anton Pottegard, a pharmacist and research fellow at the University of Southern Denmark, in Odense. "Often, the effects in these kinds of studies are quite small. But ...

MONDAY, July 20, 2015 – Here's yet another reason not to overuse antibiotics: Children treated with the antibacterial drugs may face a greater risk for developing juvenile arthritis, new research suggests. The study found that children and teens prescribed antibiotics had about twice the risk of developing juvenile arthritis compared to children the same age who were not prescribed the drugs. ...

MONDAY, July 20, 2015 – Many American parents still have misconceptions about when their children should receive antibiotics and what the medications do, a new study finds. Looking at data results spanning more than a decade, researchers saw that parents with Medicaid insurance were more likely to misunderstand appropriate antibiotic use than parents with private commercial insurance. Medicaid ...

TUESDAY, June 16, 2015 – Although surgical removal of the appendix has long been a standard treatment, a new study found that almost three-quarters of people treated with antibiotics could be spared the invasive procedure known as appendectomy. "For more than a century, appendectomy has been the standard treatment," said the study's lead author Dr. Paulina Salminen, of Turku University Hospital ...

THURSDAY, June 11, 2015 – The length of antibiotic treatment for abdominal infections can be cut in half and still be equally effective, a new study suggests. Doing so could help efforts to battle the growing problem of antibiotic resistance, the study authors said. The study – led by researchers at the University of Virginia – included more than 500 patients in the United States and Canada ...

THURSDAY, May 28, 2015 – Two new therapies to treat irritable bowel syndrome accompanied by diarrhea (IBS-D) in adults have been approved by the U.S. Food and Drug Administration. IBS, characterized by loose stools and abdominal discomfort, affects 10 percent to 15 percent of U.S. adults, the FDA said in a news release. The first drug, Viberzi, is taken twice daily with food. It stimulates ...

THURSDAY, May 28, 2015 – Two new drugs for adults with irritable bowel syndrome with diarrhea (IBS-D) were approved by the U.S. Food and Drug Administration on Wednesday. "For some people, IBS can be quite disabling, and no one medication works for all patients suffering from this gastrointestinal disorder," Dr. Julie Beitz, director of the Office of Drug Evaluation III in FDA's Center for Drug ...

May 27, 2015 – The U.S. Food and Drug Administration today approved Viberzi (eluxadoline) and Xifaxan (rifaximin), two new treatments, manufactured by two different companies, for irritable bowel syndrome with diarrhea (IBS-D) in adult men and women. According to the National Institutes of Health, patients with irritable bowel syndrome (IBS) experience a number of signs and symptoms, ...

LAVAL, Quebec, May 27, 2015 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for Xifaxan 550 mg for the treatment of IBS-D in adults. The FDA approval of Xifaxan 550 mg is based on data from three phase 3 studies, TARGET ...